PROVIDER PROFILE · NPI 1154402931
Christopher MayMD
PRESCRIBING · PART D · 2024
Total Rx claims
574
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
14
Brand share
40.9%
Top prescribed drugs
Sacubitril/Valsartan87 claims
Metoprolol Succinate76 claims
Spironolactone73 claims
Empagliflozin54 claims
Atorvastatin Calcium51 claims
QUALITY · MIPS · 2024
Final MIPS score
83.4
Quality
73.0
Cost
71.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
CROSS-REFERENCE